Option chain shows key data for Cell Source's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Cell Source.

Cell Source (OTC:CLCS) Stock, Option Chain

Cell Source Inc is a biotechnology company focused on developing cell therapy treatments focused on immunotherapy. The company is involved with the development of proprietary immune system management technology. The company's subsidiary commercializes a suite of inventions relating to certain cancer treatments. Its other products include Anti-rejection Veto Cell tolerance therapy for both matched and mismatched allogeneic bone marrow transplantations and Anti-rejection Veto Cell tolerance therapy for both matched and mismatched organ transplantation.

Cell Source Inc

News

Comments

Cell Source

Cell Source (CLCS) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga